Pancreatic secretory trypsin inhibitor is a major motogenic and protective factor in human breast milk

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 296, Issue 4, 2009, Pages

  Marchbank, Tania ^a   Weaver, Gillian ^b   Nilsen Hamilton, Marit ^c   Playford, Raymond J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^c IOWA STATE UNIVERSITY   (United States)

Author keywords

Injury; Nutrition; Repair

Indexed keywords

APROTININ; CASPASE 3; EPIDERMAL GROWTH FACTOR; INDOMETACIN; NEUTRALIZING ANTIBODY; CARRIER PROTEIN; SPINK1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ARTIFICIAL MILK; BREAST MILK; CELL MIGRATION; CELL PROLIFERATION; COLOSTRUM; CONTROLLED STUDY; ENZYME ACTIVITY; FEEDING; FEMALE; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOASSAY; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH INJURY; STOMACH MUCOSA; ANIMAL; CELL MOTION; CELL STRAIN HT29; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; PHYSIOLOGY; SPRAGUE DAWLEY RAT; STOMACH DISEASE;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; COLOSTRUM; HT29 CELLS; HUMANS; INDOMETHACIN; MILK, HUMAN; RATS; RATS, SPRAGUE-DAWLEY; STOMACH DISEASES;

EID: 67149123446     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90565.2008     Document Type: Article

References (26)

1. Bank A, Yu J, Zhang L. NSAIDs downregulate Bcl-X(L) and dissociate BAX and Bcl-X(L) to induce apoptosis in colon cancer cells. Nutr Cancer 60: 98-103, 2008.
2. Chiou SK, Mandayam S. NSAIDs enhance proteasomic degradation of survivin, a mechanism of gastric epithelial cell injury and apoptosis. Biochem Pharmacol 74: 1485-1495, 2007.
3. Drenth JP, te Morsche R, Jansen JB. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut 50: 687-692, 2002.
4. Fitzgerald AJ, Rai PS, Marchbank T, Taylor GW, Ghosh S, Ritz BW, Playford RJ. Reparative properties of a commercial fish protein hydrolysate preparation. Gut 54: 775-781, 2005.
5. Freeman TC, Playford RJ, Quinn C, Beardshall K, Poulter L, Young J, Calam J. Pancreatic secretory trypsin inhibitor in gastrointestinal mucosa and gastric juice. Gut 31: 1318-1323, 1990.
6. Freeman TC, Curry BJ, Calam J, Woodburn JR. Pancreatic secretory trypsin inhibitor stimulates the growth of rat pancreatic carcinoma cells. Gastroenterology 99: 1414-1420, 1990.
7. Kazal LA, Spicer DS, Brahinsky RA. Isolation of a crystalline trypsin inhibitor-anticoagulant protein from the pancreas. J Am Chem Soc 70: 304-340, 1948.
8. Kim WH, Yeo M, Kim MS, Chun SB, Shin EC, Park JH, Park IS. Role of caspase-3 in apoptosis of colon cancer cells induced by nonsteroidal anti-inflammatory drugs. Int J Colorectal Dis 15: 105-111, 2000.
9. Levi S, Shaw-Smith C. Non-steroidal anti-inflammatory drugs: how do they damage the gut? Br J Rheumatol 33: 605-612, 1994.
10. Marchbank T, Chinery R, Hanby AM, Poulsom R, Elia G, Playford RJ. Distribution and expression of pancreatic secretory trypsin inhibitor and its possible role in epithelial restitution. Am J Pathol 148: 715-722, 1996.
11. Marchbank T, Mahmood A, Fitzgerald AJ, Domin J, Butler M, Goodlad RA, Elia G, Cox HM, van Heel DA, Ghosh S, Playford RJ. Human pancreatic secretory trypsin inhibitor stabilizes intestinal mucosa against noxious agents. Am J Pathol 171: 1462-1473, 2007.
12. Marshman E, Ottewell PD, Potten CS, Watson AJ. Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine. J Pathol 195: 285-292, 2001.
13. Nakayama GR, Caton MC, Nova MP, Parandoosh Z. Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods 204: 2205-2208, 1997.
14. Niinobu T, Ogawa M, Shibata T, Murata A, Nishibe S, Mori T, Ogata N. Specific binding of human pancreatic secretory trypsin inhibitor to various cultured cells. Res Commun Chem Pathol Pharmacol 53: 245-248, 1986.
15. Ojala R, Ruuska T, Karikoski R, Ikonen RS, Tammela O. Gastroesophageal endoscopic findings and gastrointestinal symptoms in preterm neonates with and without perinatal indomethacin exposure. J Pediatr Gastroenterol Nutr 32: 182-188, 2001.
16. Okada M, Ohmura E, Kamiya Y, Murakami H, Onoda N, Iwashita M, Wakai K, Tsushima T, Shizume K. Transforming growth factor (TGF)-α in human milk. Life Sci 48: 1151-1156, 1991.
17. Petruzzelli M, Vacca M, Moschetta A, Cinzia Sasso R, Palasciano G, van Erpecum KJ, Portincasa P. Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts. Clin Biochem 40: 503-510, 2007.
18. Playford RJ, Vesey DA, Haldane Alison MR, Calam J. Dose-dependent effects of fentanyl on indomethacin-induced gastric damage. Digestion 49: 198-203, 1991.
19. Playford RJ, Macdonald CE, Johnson WS. Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders (Review). Am J Clin Nutr 72: 5-14, 2000.
20. Playford RJ, Belo A, Poulsom R, Fitzgerald AJ, Harris K, Pawluczyk I, Ryon J, Darby T, Nilsen-Hamilton M, Ghosh S, Marchbank T. Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair. Gastroenterology 131: 809-817, 2006.
21. Playford RJ, Marchbank T, Chinery R, Evison R, Pignatelli M, Boulton RA, Thim L, Hanby AM. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 108: 108-116, 1995.
22. Playford RJ, Hanby AM, Gschmeissner S, Peiffer LP, Wright NA, McGarrity T. The epidermal growth factor receptor (EGF-R) is present on the basolateral, but not the apical, surface of enterocytes in the human gastrointestinal tract. Gut 39: 262-266, 1996.
23. Read LC, Francis GL, Wallace JC, Ballard FJ. Growth factor concentrations and growth-promoting activity in human milk following premature birth. J Dev Physiol 7: 135-145, 1985.
24. Royer P. Breast feeding and biological development. Acta Paediatr Scand 67: 554-556, 1978.
25. Ryon J, Bendickson L, Nilsen-Hamilton M. High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. Biochem J 367: 271-277, 2002.
26. Schroll S, Sarlette Ahrens K A, Manns MP, Göke M. Effects of azathioprine and its metabolites on repair mechanisms of the intestinal epithelium in vitro. Regul Pept 131: 1-11, 2005.